Epidermal Growth Factor Receptor clinical trials at UCLA
1 research study open to eligible people
Showing trials for
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
open to eligible people ages 18 years and up
The purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors. To accomplish this, the investigators propose obtaining image-guided measures of tissue pH and biopsied tissue in tumor areas selected for bulk resection surgery. Investigators will then correlate the imaging measurements with pH, RNA expression, protein expression, and bioenergetics measurements of key glycolytic enzymes.
Los Angeles, California
Our lead scientists for Epidermal Growth Factor Receptor research studies include Benjamin Ellingson, PhD.
Last updated: